A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate damaged p53. This vital cancer protector protein is frequently disabled in several forms of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research